Literature DB >> 12218596

Risk factors for microalbuminuria in children with sickle cell anemia.

Patricia Geraty McBurney1, Coral Dawn Hanevold, Caterina Maria Hernandez, Jennifer Lynn Waller, Kathleen Mood McKie.   

Abstract

PURPOSE: To determine the prevalence of microalbuminuria and to establish clinical characteristics associated with microalbuminuria in children with sickle cell anemia. PATIENTS AND METHODS: Urine samples of all children (homozygous SS) followed in the Medical College of Georgia's Children's Medical Center Sickle Cell Clinic were screened for microalbuminuria. Random samples were obtained from continent patients at routine office visits between September 1996 and November 1999. A retrospective chart survey was performed to determine clinical correlates for microalbuminuria. Medical records were reviewed for age, sex, hemoglobin, and episodes of pneumonia, pain, aplasia, acute chest syndrome, priapism, and avascular necrosis. Demographic and clinical variables were compared with microalbuminuria by univariate and multivariate logistic regression.
RESULTS: One hundred forty-two patients ages 21 months to 20 years made up the study group. The prevalence of microalbuminuria was 19%. Both increasing age and a lower hemoglobin level were found to correlate with microalbuminuria. By multivariate analysis, boys with microalbuminuria were likely to have a lower hemoglobin level and girls with microalbuminuria were likely to be older. None of the following factors were significantly related to microalbuminuria: pain, pneumonia, acute chest syndrome, priapism, avascular necrosis, or aplastic episodes.
CONCLUSIONS: Microalbuminuria is strongly and directly related to age and strongly and inversely related to hemoglobin levels. Identification of risk factors for microalbuminuria may allow earlier intervention to prevent renal complications in patients with sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218596     DOI: 10.1097/00043426-200208000-00013

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  23 in total

1.  Biomarkers for early detection of sickle nephropathy.

Authors:  Nambirajan Sundaram; Michael Bennett; Jamie Wilhelm; Mi-Ok Kim; George Atweh; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

2.  Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease.

Authors:  Lauren J Becton; Ram V Kalpatthi; Elizabeth Rackoff; Deborah Disco; John K Orak; Sherron M Jackson; Ibrahim F Shatat
Journal:  Pediatr Nephrol       Date:  2010-05-27       Impact factor: 3.714

3.  Prevalence of microalbuminuria among secondary school children.

Authors:  A N Okpere; I C Anochie; F U Eke
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

Review 4.  Sickle cell nephropathy: challenging the conventional wisdom.

Authors:  Amy M Becker
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

5.  Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease.

Authors:  Ashley Thrower; Emily J Ciccone; Poulami Maitra; Vimal K Derebail; Jianwen Cai; Kenneth I Ataga
Journal:  Br J Haematol       Date:  2018-11-21       Impact factor: 6.998

6.  Glomerular hyperfiltration and albuminuria in children with sickle cell anemia.

Authors:  Banu Aygun; Nicole A Mortier; Matthew P Smeltzer; Jane S Hankins; Russell E Ware
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

7.  Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.

Authors:  Amy Geard; Gift D Pule; Bernard Chetcha Chemegni; Valentina J Ngo Bitoungui; Andre P Kengne; Emile R Chimusa; Ambroise Wonkam
Journal:  Br J Haematol       Date:  2017-05-03       Impact factor: 6.998

8.  Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease.

Authors:  Davoud Mohtat; Rosemary Thomas; Zangfang Du; Yaa Boakye; Thomas Moulton; Catherine Driscoll; Robert Woroniecki
Journal:  Pediatr Nephrol       Date:  2010-11-25       Impact factor: 3.714

Review 9.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

10.  Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1).

Authors:  Ilham Youssry; Samuel Makar; Rania Fawzy; Manal Wilson; Ghada AbdAllah; Eman Fathy; Happy Sawires
Journal:  Pediatr Nephrol       Date:  2015-08-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.